Biomerica (BMRA) Cash & Equivalents Growth (5y) (2015 - 2026)
Biomerica (BMRA) Cash & Equivalents Growth (5y) (2015 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.32 Bn | 175.02 Bn | 6.27 Bn |
| 2 | Stryker | 128.75 Bn | 125.88 Bn | 3.81 Bn |
| 3 | Medtronic | 107.83 Bn | 98.61 Bn | 6.41 Bn |
| 4 | Boston Scientific | 67.61 Bn | 66.15 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 48.13 Bn | 44.45 Bn | 1.29 Bn |
| 6 | Dexcom | 28.26 Bn | 27.14 Bn | 750.30 Mn |
| 7 | GE HealthCare Technologies | 27.78 Bn | 25.50 Bn | 1.98 Bn |
| 8 | Smith & Nephew | 26.99 Bn | 26.41 Bn | - |
| 9 | Koninklijke Philips | 23.92 Bn | 20.80 Bn | 2.07 Bn |
| 10 | Biomerica | 4.88 Mn | 3.54 Mn | -44,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Feb 28, 2026 | -24.01% |
| Nov 30, 2025 | -14.86% |
| Aug 31, 2025 | -15.21% |
| May 31, 2025 | -18.76% |
| Feb 28, 2025 | 5.04% |
| Nov 30, 2024 | 22.75% |
| Aug 31, 2024 | 28.41% |
| May 31, 2024 | 43.44% |
| Feb 29, 2024 | 42.10% |
| Nov 30, 2023 | 44.69% |
| Aug 31, 2023 | 68.75% |
| May 31, 2023 | 51.82% |
| Feb 28, 2023 | 41.15% |
| Nov 30, 2022 | 44.02% |
| Aug 31, 2022 | 41.24% |
| May 31, 2022 | 37.01% |
| Feb 28, 2022 | 45.85% |
| Nov 30, 2021 | 34.91% |
| Aug 31, 2021 | 22.42% |
| May 31, 2021 | 17.33% |